Andrew Jonathan Hillman: resume
Andrew Jonathan Hillman is a Dallas healthcare compliance and regulatory expert witness, retained through counsel, and a senior paralegal.
The full record.
Three decades operating in FDA-regulated healthcare and biotech. Current focus spans FDA regulatory strategy, healthcare compliance, and interventional procedures. This page is the living resume, kept current and verifiable.
Exosome and mesenchymal stem cell-derived extracellular vesicle products are not approved by the FDA for any indication. References here describe published scientific literature. They do not describe an available treatment. Targeted Osmotic Lysis is investigational. It has not been approved by the FDA for any indication and it is not available as a treatment.
At a glance
- Name
- Andrew Jonathan Hillman
- Domicile
- Dallas, Texas
- Principal role
- Principal, Hillman Ventures family office
- Operating focus
- FDA-regulated biologics · interventional procedures
- Regulatory focus
- FDA CBER · 351(a) BLA pathway · 21 CFR 1271 · IND and IRB design
- Verified identity
- Wikidata Q139969699 · LinkedIn /in/andrew-hillman-dallas
- Public record
- andrewhillmanrecord.com
Current focus
Interventional procedures
Interventional procedure operations and adjunctive regenerative protocols.

The Hillman Letter
Substack publication on healthcare regulatory strategy, frontier biotech operating, and compliance. thehillmanletter.substack.com
AI A Pro Research
AI-assisted protocol research for regenerative medicine in professional sports. Evidence-based protocol design from peer-reviewed data, compiled for IND and IRB submission. aiapro.org
Career timeline
-
2022–Now
Principal · Hillman Ventures
FDA-regulated biologics and interventional procedures. Operating focus on FDA-regulated and IND/IRB-pathway programs.
-
2010–2018
Co-Owner · Next Health LLC
Co-owner. Healthcare and wellness operations in Dallas. Ownership period concluded.
-
2000s
Operating roles · FDA-regulated healthcare
Multiple operating roles across pharmacy, laboratory, and healthcare-services entities in Texas, building the operating foundation that underwrites the current frontier-biotech work.
Philanthropy and affiliations
Chabad of Dallas
Ongoing support.
Heroes for Israel
Ongoing support.
Andrew Hillman Scholarship and Biotech Grant
Founded scholarship and biotech grant programs. See andrewhillman.org for details.
Mensa International
Member.
Expert witness and advisory
Available for advisory engagements in healthcare regulatory, FDA biologics pathway strategy, pharmacy and laboratory operations, and healthcare-fraud compliance design. Texas Notary Public. Engagements through andrewhillmanadvisor.com.
How to verify
- Wikidata
- Q139969699 · COI-disclosed editor User:Optimizedus per WMF ToU §4
- linkedin.com/in/andrew-hillman-dallas
- Public record
- andrewhillmanrecord.com
- Advisory profile
- andrewhillmanadvisor.com
- Ventures site
- hillmanv.com
- Cancer initiative
- fixcancer.org
- Research initiative
- aiapro.org
- Writing
- thehillmanletter.substack.com
Andrew Jonathan Hillman
Dallas senior paralegal and healthcare compliance expert witness. Not an attorney.
Expert witness page · Publications · Videos · Book a meeting
Profiles
- Andrew Hillman, Dallas on LinkedIn
- ORCID
- Wikidata
- Wikipedia
- Google Scholar
- NCBI My Bibliography
- OSF
- FIBRADISC trademark application
- Academia.edu
- X
- Telegram
- About.me
- Muck Rack
- BookBub
- Issuu
- Quora
- GitHub Pages (Andrew Jonathan Hillman)
- GitHub Pages (senior paralegal)
- Expert witness landing (Cloudflare Pages)
- Official profiles landing (Cloudflare Pages)
- Sessionize
- 351 or 361? How FDA Decides What Counts as a Biologic
- Six Compliance Patterns Behind Federal Healthcare Enforcement
- AI Governance Rules for Healthcare Teams
- Threads
- The Hillman Letter (Flipboard magazine)
- Wellfound
- The Hillman Letter
- Flickr
- WordPress Blog
